【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Uveitis Overview 11
Therapeutics Development 12
Pipeline Products for Uveitis – Overview 12
Pipeline Products for Uveitis – Comparative Analysis 13
Uveitis – Therapeutics under Development by Companies 14
Uveitis – Therapeutics under Investigation by Universities/Institutes 18
Uveitis – Pipeline Products Glance 19
Late Stage Products 19
Clinical Stage Products 20
Early Stage Products 21
Uveitis – Products under Development by Companies 22
Uveitis – Products under Investigation by Universities/Institutes 26
Uveitis – Companies Involved in Therapeutics Development 27
AbbVie Inc. 27
Aciont Inc. 28
Apitope International NV 29
BBB Therapeutics B.V. 30
Can-Fite BioPharma Ltd. 31
Clearside BioMedical, Inc. 32
Effimune SAS 33
Eleven Biotherapeutics Inc. 34
Endocyte, Inc. 35
Enzo Biochem, Inc. 36
EyeGate Pharmaceuticals, Inc. 37
ForSight VISION4, Inc. 38
HanAll Biopharma Co., Ltd. 39
Icon Bioscience, Inc. 40
IMMD Inc. 41
Johnson & Johnson 42
Neuroptis Biotech 43
Novartis AG 44
Ocata Therapeutics, Inc. 45
OncoNOx ApS 46
Panoptes Pharma Ges.m.b.H. 47
Pfizer Inc. 48
pSivida Corp. 49
Regeneron Pharmaceuticals, Inc. 50
Santen Pharmaceutical Co., Ltd. 51
SynDevRx, Inc. 52
TxCell SA 53
Virogenomics, Inc. 54
XOMA Corporation 55
Uveitis – Therapeutics Assessment 56
Assessment by Monotherapy Products 56
Assessment by Target 57
Assessment by Mechanism of Action 59
Assessment by Route of Administration 61
Assessment by Molecule Type 63
Drug Profiles 65
2B3-201 – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
adalimumab – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
ATXUV-1 – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
ATXUV-2 – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
B27-PD – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
celecoxib – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
CF-101 – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
Col-Treg – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
Cytectin – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
dexamethasone acetate – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
Dexamethasone Sodium Phosphate-Visulex – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
Drugs to Inhibit Aldose Reductase for Immunology, Ophthalmology, Infectious Disease, Metabolic and Respiratory Disorders – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
EBI-028 – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
EC-1496 – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
EC-1669 – Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
fluocinolone acetonide – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
FR-104 – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
gevokizumab – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
HL-036 – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
IBI-70090 – Drug Profile 94
Product Description 94
Mechanism of Action 94
R&D Progress 94
IMD-0354 – Drug Profile 95
Product Description 95
Mechanism of Action 95
R&D Progress 95
INV-17 – Drug Profile 96
Product Description 96
Mechanism of Action 96
R&D Progress 96
LFG-316 – Drug Profile 97
Product Description 97
Mechanism of Action 97
R&D Progress 97
lodamin – Drug Profile 99
Product Description 99
Mechanism of Action 99
R&D Progress 99
NOP-3 – Drug Profile 100
Product Description 100
Mechanism of Action 100
R&D Progress 100
NS-2 – Drug Profile 101
Product Description 101
Mechanism of Action 101
R&D Progress 101
OX-1001 – Drug Profile 102
Product Description 102
Mechanism of Action 102
R&D Progress 102
PA-2612 – Drug Profile 103
Product Description 103
Mechanism of Action 103
R&D Progress 103
Peptides to Modulate TCR for Uveitis – Drug Profile 104
Product Description 104
Mechanism of Action 104
R&D Progress 104
plastoquinone decyl triphenylphosphonium bromide – Drug Profile 105
Product Description 105
Mechanism of Action 105
R&D Progress 105
PP-001 – Drug Profile 107
Product Description 107
Mechanism of Action 107
R&D Progress 107
PPL-003 – Drug Profile 108
Product Description 108
Mechanism of Action 108
R&D Progress 108
Recombinant Enzymes for Uveitis – Drug Profile 109
Product Description 109
Mechanism of Action 109
R&D Progress 109
sarilumab – Drug Profile 110
Product Description 110
Mechanism of Action 110
R&D Progress 110
sirolimus – Drug Profile 112
Product Description 112
Mechanism of Action 112
R&D Progress 112
Small Molecules to Inhibit Kinase for Uveitis and Inflammatory Bowel Disease – Drug Profile 114
Product Description 114
Mechanism of Action 114
R&D Progress 114
Stem Cell Therapy for Autoimmune Diseases – Drug Profile 115
Product Description 115
Mechanism of Action 115
R&D Progress 115
triamcinolone acetonide – Drug Profile 116
Product Description 116
Mechanism of Action 116
R&D Progress 116
V-404 – Drug Profile 117
Product Description 117
Mechanism of Action 117
R&D Progress 117
Uveitis – Recent Pipeline Updates 118
Uveitis – Dormant Projects 147
Uveitis – Discontinued Products 150
Uveitis – Product Development Milestones 151
Featured News & Press Releases 151
Jan 05, 2015: Clearside Biomedical Initiates Phase 2 Clinical Trial For the Treatment of Macular Edema Associated With Non-Infectious Uveitis 151
Dec 18, 2014: Aldeyra Therapeutics Submits FDA IND Filing for Noninfectious Anterior Uveitis 151
Dec 17, 2014: TxCell Receives EU Orphan Drug Designation For Col-Treg In The Treatment Of Non-Infectious Uveitis 152
Dec 16, 2014: Aldeyra Therapeutics Abstract Accepted at 2015 American Academy of Allergy Asthma & Immunology Annual Meeting 153
Dec 16, 2014: Portage announces further successful validation of its new proprietory cell permeable peptide platform technology 153
Oct 28, 2014: TxCell achieves positive results for Col-Treg in a model of autoimmune uveitis 154
Oct 15, 2014: Clearside Biomedical Announces Ongoing Results in Phase 1/2 Clinical Trial in Patients with Non-infectious Uveitis 155
Oct 06, 2014: Portage Announces Additional Consultants To Expedite Its PPL-003 Development Programs 155
May 22, 2014: Col-Treg granted Advanced Therapy Medicinal Product classification by the European Medicines Agency 156
May 20, 2014: AbbVie Receives Orphan Drug Designation for HUMIRA from the U.S. Food and Drug Administration for the Investigational Treatment of Certain Forms of Non-infectious Uveitis 157
Appendix 158
Methodology 158
Coverage 158
Secondary Research 158
Primary Research 158
Expert Panel Validation 158
Contact Us 158
Disclaimer 159
【レポート販売概要】
■ タイトル：ぶどう膜炎(Uveitis)：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Uveitis - Pipeline Review, H1 2015
■ 発行日：2015年3月11日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6260IDB
■ 調査対象地域：グローバル
- 世界のポータブル医療機器市場：心臓、呼吸、血行、健康機器などMobile healthcare market means Portable (movable/compact) healthcare products with integrated wireless communication capabilities (using various types of WLAN, WPAN and WMAN technologies with different protocols). These products are generally used for measuring & monitoring data in combination with display or representation of the data on a mobile computing device, typically a smart-phone or a tab …
- 帯状疱疹ワクチン（Herpes Zoster vaccine）の世界市場機会分析Varicella-zoster virus is a ubiquitous human alphaherpesvirus, which after infection in childhood causes a relatively mild self-limiting illness. However, if the virus becomes reactivated later on in life it can cause a painful rash (shingles), often leading to postherpetic neuralgia (PHN). PHN has a significant economic burden because patients require systemic anti-viral therapy and pain manageme …
- 世界の環境センサ及びモニター市場2015The Global Environmental Sensor and Monitor Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Environmental Sensor and Monitor industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Environmental Sensor and Monitor market analysis is provided for the int …
- 溶接用呼吸用保護具の世界市場2017-2021ABSTRACTAbout Welding Respiratory Systems Welding is among several key application areas of respiratory protective equipment. Workers in the welding industry including welders, solderers, and brazers are exposed to various occupational hazards such as intense visible light and harmful radiation, burns, sparks, and airborne particulate matter. In addition, workers face risks such as lung cancer, ch …
- 固体経口剤形（OSDF）賦形剤の世界市場About OSDF Excipients OSDF excipients are chemical compounds that are added along with API and other chemicals during the manufacture of a drug. The sole purpose of the excipients is to hold the components together in the different forms of oral dosage. Sometimes, these excipients also act as drug releasers by releasing controlled amount of the medication after ingestion of the same. The global OS …
- Pioneer Natural Resources Company：石油・ガスバリューチェーン分析レポート2013Pioneer Natural Resources Company Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Pioneer Natural Resources Company" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Pioneer Natural Resources Company”. The report provides key information relating to oil and gas assets of the company along with its operations …
- 日本の自動微生物検査市場2014Complete report $8,850. DataPack (test volumes, sales forecasts, supplier shares) $5,700. “Japanese Automated Microbiology Market 2014” is a new analysis of major business opportunities emerging in the Japanese automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications o …
- Zonegran (Epilepsy)：市場予測と分析（～2022）Zonegran (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Zonegran (Epilepsy) - Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AE …
- アメリカの電子レンジ市場2016-2020About Consumer Preferences for Microwave Ovens Consumers are now preferring microwave ovens, which are energy-efficient and have a high visual appeal. Consumers have started preferring built-in microwave ovens and are willing to pay premium prices for products that offer smart features or better aesthetic appeal. Consumers prefer buying electronic and household appliances during seasonal sales suc …
- クラウドCDN（コンテンツデリバリネットワーク）の世界市場予測（～2021）MarketsandMarkets forecasts the Cloud Content Delivery Network market size to grow from USD 1.81 Billion in 2016 to USD 6.23 Billion by 2021, at an estimated Compound Annual Growth Rate (CAGR) of 28.0%. Major factors contributing to the growth of the cloud CDN market are growing rich media file contents, video content, increasing use of connected and smart devices, and proliferation of rich media …
- 包装用テープ印刷の世界市場：製品種類、材料、印刷インキ、印刷方式、需要先、地域別分析MarketsandMarkets projects the global packaging tape printing market size to grow from USD 21.42 Billion in 2015 to USD 28.78 Billion by 2020, at a CAGR of 6.08% from 2015 to 2020. This high growth can be attributed to the fact that a significant number of brand owners are harnessing the printing technology over the packaging tapes. Growth in the packaging printing industry, demand for aesthetic a …
- 世界における手術用メッシュの製品パイプライン動向2015Surgical Mesh - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Surgical Mesh - Pipeline Review, 2015" provides an overview of Surgical Mesh currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipelin …
- ケモインフォマティックスの世界市場分析：用途別（化学分析、医薬品発見、医薬品バリデーション）、セグメント予測The global chemoinformatics market is expected to reach over USD 21.18 billion by 2024 according to a new report published by Grand View Research, Inc. Some major determinants influencing the market growth include the constantly improving modern drug development processes, increasing use of in-silico techniques in research, and the advantages associated with employing the chemoinformatics approach …
- デニム製高級ジーンズの世界市場2015-2019About Premium Denim Market The premium denim jeans market includes all those denim jeans which cost $160 and above. The end users for these products are usually the HNWIs who are willing to spend more money for a good pair of jeans. What sets it apart from the normal jeans is the comfortable fit and premium quality of the cloth, as well as the label attached to them. Technavio analyst forecast the …
- マネージドセキュリティサービスのグローバル市場動向（2014-2018）About Managed Security Services Managed security services are information and network security services that are outsourced to third-party service providers. These providers offer network boundary protection, including managed services for firewalls, intrusion detection systems, and virtual private networks; security monitoring; managed anti-virus; content filtering; information security risk asse …
